Ads
related to: radiation therapy programs in oklahoma
Search results
Results From The WOW.Com Content Network
Unique services at OU Medical Center include comprehensive cancer care including a Gamma Knife Center for treating brain tumors that can't be treated by conventional methods, a Bone Marrow Transplant Center and Oklahoma's newest and largest Radiation Therapy Center. [2] OU Medical Center also houses the Oklahoma Transplant Center.
Oklahoma CyberKnife is a cancer treatment center based in Oklahoma. The center treats malignant and benign tumors in the lungs, spine, brain, liver, pancreas, eye, prostate and kidney using CyberKnife technology. Oklahoma CyberKnife has treated patients from around Oklahoma as well as patients from bordering states.
WBRT has been shown to alleviate symptoms, decrease the use of corticosteroids needed to control tumor-associated edema, and potentially improve overall survival. [2] ...
Integris Health was created in 1983 in order to serve as the parent corporation and to provide management and administrative support to Integris Baptist Medical Center Inc. [5] However, the network of hospitals that now comprises Integris Health, was born out of a series of Oklahoma healthcare providers merging over the span of three years from 1992 to 1995, with additional hospitals brought ...
A. Addario Lung Cancer Medical Institute; AIM at Melanoma Foundation; Alliance for Clinical Trials in Oncology; Alvin J. Siteman Cancer Center; American Association for Cancer Research
It also offers ASRT members the opportunity to earn continuing education credit through its Directed Reading program. Radiation Therapist, published twice a year, focuses on technical advances in radiation oncology. It, too, features a Directed Reading program. ASRT Scanner is the society's member magazine. In addition, the ASRT operates a ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. [1] It has the potential to provide highly targeted treatment, especially to microscopic tumour cells.